Hyperion DeFi, Inc. (HYPD) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Hyperion DeFi, Inc. (HYPD) closed at USD 3.09 on 2026-10-14, a change of -62.2 % over the past year, with a market capitalization of USD 47.89M.

Hyperion DeFi, Inc. recent closing prices

DateClose (USD)
2026-10-143.09
2026-10-133.36
2026-10-123.47
2026-10-093.40
2026-10-083.37
2026-10-073.59
2026-10-063.82

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Hyperion DeFi, Inc. key figures

Previous close
USD 3.09 (2026-10-14)
1-year change
-62.2 %
Market cap
USD 47.89M
Enterprise value
USD 48.22M
P/E ratio (trailing)
-0.52
P/E ratio (forward)
n/a
EPS (trailing)
-6.03
EPS (forward)
n/a
PEG ratio
n/a
Price to book
0.47
Revenue growth
n/a
Earnings growth
n/a
Dividend per share (trailing)
0.00
Short ratio
1.98
Employees
9
Analyst consensus (third-party)
none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Hyperion DeFi, Inc.

Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Hyperion DeFi, Inc. and compare it with other stocks.

Analyze HYPDAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Hyperion DeFi, Inc. shares.